Case Study

Drug R&D Services Leader Implements A Collaborative Enterprise ELN To Advance Research

Source: Dassault Systèmes Americas
iStock-1213006106-lab-research-microscope

This BIOVIA customer has offered industry-leading drug discovery and development services for over 25 years. Its success lies in its fully integrated, holistic approach to small molecule drug discovery, spanning from target identification to investigational new drug (IND) submissions. The company has global research operations at five sites, with each site specializing in one part of the drug R&D value chain. Central operations, screening services, and in vitro and in vivo biological studies are conducted at one site; medicinal chemistry services, computational chemistry, structural biology, and DMPK studies are based in another; and additional medicinal chemistry support and library management and services occur elsewhere.

In a demanding and increasingly distributed research environment, drug discovery alliance companies can only attract and maintain collaborations by being responsive and providing high quality results as quickly as possible.

What mattered to this BIOVIA customer in meeting collaboration demands, however, was being able to rapidly collect together project information to deliver reports and data, fulfill patent submissions, or leverage and build on past work.

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Dassault Systèmes Americas